tetano
Editor, Senior Moderator
Medicine (Baltimore)
. 2021 Feb 12;100(6):e24544.
doi: 10.1097/MD.0000000000024544.
Effect of low-dose aspirin on mortality and viral duration of the hospitalized adults with COVID-19
Qiang Liu[SUP] 1 [/SUP], Na Huang[SUP] 1 [/SUP], Anni Li[SUP] 1 [/SUP], Yuanhong Zhou[SUP] 1 [/SUP], Liang Liang[SUP] 1 [/SUP], Xinyu Song[SUP] 1 [/SUP], Zhanqiu Yang[SUP] 2 [/SUP], Xiaolin Zhou[SUP] 1 [/SUP]
Affiliations
Abstract
To clarify the effect of aspirin on mortality and viral duration in adults infected with respiratory syndrome coronavirus 2 (SARS-Cov-2).After propensity score-matched (PSM) case-control analyses 24 pairs of patients were enrolled and followed up for 2 months. Both 30-day and 60-day mortality in the aspirin group were significantly lower than that in the non-aspirin group (P = .021 and P = .030, respectively). The viral duration time between the 2 groups was not significantly different (P = .942).Among adults (with hypertension, cardiovascular diseases) infected with SARS-Cov-2, low-dose aspirin medication (100 mg/day) was associated with lower risk of mortality compared with non-aspirin users.
. 2021 Feb 12;100(6):e24544.
doi: 10.1097/MD.0000000000024544.
Effect of low-dose aspirin on mortality and viral duration of the hospitalized adults with COVID-19
Qiang Liu[SUP] 1 [/SUP], Na Huang[SUP] 1 [/SUP], Anni Li[SUP] 1 [/SUP], Yuanhong Zhou[SUP] 1 [/SUP], Liang Liang[SUP] 1 [/SUP], Xinyu Song[SUP] 1 [/SUP], Zhanqiu Yang[SUP] 2 [/SUP], Xiaolin Zhou[SUP] 1 [/SUP]
Affiliations
- PMID: 33578548
- DOI: 10.1097/MD.0000000000024544
Abstract
To clarify the effect of aspirin on mortality and viral duration in adults infected with respiratory syndrome coronavirus 2 (SARS-Cov-2).After propensity score-matched (PSM) case-control analyses 24 pairs of patients were enrolled and followed up for 2 months. Both 30-day and 60-day mortality in the aspirin group were significantly lower than that in the non-aspirin group (P = .021 and P = .030, respectively). The viral duration time between the 2 groups was not significantly different (P = .942).Among adults (with hypertension, cardiovascular diseases) infected with SARS-Cov-2, low-dose aspirin medication (100 mg/day) was associated with lower risk of mortality compared with non-aspirin users.
